Effect of Oryeongsan on Spontaneously Hypertensive Rat decrease of Blood Pressure and Vasodilatory |
Jang, Youn Jae
(Department of Phygiology, College of Korean Medicine, Wonkwnag University)
Kim, Hye Yoom (Department of Phygiology, College of Korean Medicine, Wonkwnag University) Hong, Mi Hyeon (Department of Phygiology, College of Korean Medicine, Wonkwnag University) Yoon, Jung Joo (Department of Phygiology, College of Korean Medicine, Wonkwnag University) Lee, Ho Sub (Department of Phygiology, College of Korean Medicine, Wonkwnag University) Kang, Dae Gill (Department of Phygiology, College of Korean Medicine, Wonkwnag University) |
1 | Escudero EM, Hurtado de MCC, Perez NG, Tufare AL. Echocardiographic assessment of left ventricular midwall mechanics in spontaneously hypertensive rats. Eur J Echocardiogr, 2004;5(3);169-175, DOI |
2 | Devereux RB, Pickering TG, Alderman MH, Chien S, Borer JS. Laragh JH. Left ventricular hypertrophy in hypertension. Prevalence and relationship to pathophysiologic variables. Hypertension 1987;9: 53-60. |
3 | Mancia G, Omboni S, Parati G. The importance of blood pressure variability in hypertension. Blood Press Monit. 2000;5:S9-S15. DOI |
4 | Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36. DOI |
5 | Cho E, Kim M, Ko YS, Lee HY, Song M, Kim HK, Cho WY, Jo SK. Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model. Nephrol. Dial. Transplant. 2013;28:2766-2778. DOI |
6 | Moubarak M, Jabbour H, Smayra V, Chouery E, Saliba Y, Jebara V, Fares N. Cardiorenal syndrome in hypertensive rats: Microalbuminuria, inflammation and ventricular hypertrophy. Physiol. Res. 2012;61:13-24. |
7 | S Godo, H Shimokawa. Endothelial Functions. Arterioscler Thromb Vasc Biol. 2017;Sep;37(9):e108-e114. |
8 | Waghe P, Sarath TS, Gupta P, Kandasamy K, Choudhury S, Kutty HS, Mishra SK, Sarkar SN. Arsenic causes aortic dysfunction and systemic hypertension in rats: Augmentation of angiotensin II signaling. Chem. Biol. Interact. 2015;237:104-114. DOI |
9 | Flanagan ET, Buckley MM, Aherne CM, Lainis F, Sattar M, Johns EJ. Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats. Exp. Physiol. 2008;93:1058-1064. DOI |
10 | Ichiki T, Usui, M, Kato M, Funakoshi Y, Ito K, Egashira K, Takeshita A. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 1998;31:342-348. DOI |
11 | JY Kang, KW Kang, MJ Jeong, HJ Kim, IS Jang, A Survey of Hypertension Treatment in Korean Medicine. The Journal of Internal Korean Medicine. 2016;37(6):1022-1029. DOI |
12 | He L, Rong X, Jiang J, M Liu, P Q, Li L. Amelioration of anti-cancer agent adriamycin-induced nephritic syndrome in rats by Wulingsan (Gorei-San), a blended traditional Chinese herbal medicine. Food Chem Toxicol. 2008;46:1452. DOI |
13 | Pravenec M, Kren V, Landa V, Mlejnek P, Musilova A, Silhavy J, Simakova M, Zidek V. Recent progress in the genetics of spontaneously hypertensive rats. Physiol Res. 2014;63(Suppl 1):S1-8. |
14 | Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 1963;27:282-293. DOI |
15 | Bing OH, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, Sen S, Conrad CH. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J. Mol. Cell. Cardiol. 1995;27:383-396. DOI |
16 | Intengan HD, Schiffrin EL. Vascular remodeling in hypertension:Roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38: 581-587. DOI |
17 | Shibasaki Y, Masaki H, Nishiue T, Nishikawa M, Matsubara H, Iwasaka T. Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. Nephron. 2002;90(3):256-61. DOI |
18 | Raman SV. The hypertensive heart. J. Am. Coll. Cardiol. 2010;55:91-96. DOI |
19 | Zanchetti A. Cardiac hypertrophy as a target of antihypertensive therapy. Nat Rev Cardiol. 2010;7:66-67. DOI |
20 | Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension, 1993;21:391-397. DOI |
21 | Mitchell CJ, Churchward-Venne TA, Parise G, Bellamy L, Baker SK, Smith K, Atherton PJ, Phillips SM. Acute post-exercise myofibrillar protein synthesis is not correlated with resistance training-induced muscle hypertrophy in young men. PLoS ONE, 2014;9:e89431. DOI |
22 | Hultstrom M. Development of structural kidney damage in spontaneously hypertensive rats. J Hypertens. 2012;Jun:30(6):1087-91. DOI |
23 | Pinto YM, Paul M, Ganten D. Lessons from rat models of hypertension:From Goldblatt to genetic engineering. Cardiovasc. Res. 1998;39:77-88. DOI |
24 | Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003;108:560-565. DOI |
25 | Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995;91: 161-170. DOI |
26 | Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, Gustafsson H, Petersen J, Adams MA. Renin-angiotensin system in neonatal rats: Induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int. 1994;45:485-492. DOI |
27 | Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA. Angiotensin II regulates nephrogenesis and renal vascular development. Am. J. Physiol. 1995;269:F110-F115. |
28 | Kim HY, Ahn YM, Na SW, Jang YJ, Kang DG, Lee HS, Cho KW. Oryeongsan (Wulingsan) ameliorates impaired ANP secretion of atria from spontaneously hypertensive rats. Biomed Pharmacother. 2022;146:112433. DOI |
29 | Frohlich ED. An updated concept of left ventricular hypertrophy risk in hypertension. Ochsner J. 2009;9:181-190. |
30 | Lerman LO, Kurtz TW, Touyz RM, Ellison DH, Chade AR, Crowley SD, Mattson DL, Mullins JJ, Osborn J, Eirin A, Reckelhoff JF, Iadecola C, Coffman TM. Animal Models of Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2019;73(6):e87-e120 |
31 | Katholi RE, Couri DM. Left ventricular hypertrophy: Major risk factor in patients with hypertension: Update and practical clinical applications. Int. J. Hypertens. 2011;495349. |
32 | Creemers EE. Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc. Res. 2011;89:265-272. DOI |
33 | Eriguchi M. Tsuruya K, Haruyama N, Yamada S, Tanaka S, Suehiro T, Noguchi, H, Masutani K, Torisu K, Kitazono T. Renal denervation has blood pressure-independent protective effects on kidney and heart in a rat model of chronic kidney disease. Kidney Int. 2014;87:16-127. |
34 | Cardinale JP, Sriramula S, Pariaut R, Guggilam A, Mariappan N, Elks C, Francis J. HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension 2010;56:437-444. DOI |
35 | Elks CM, Mariappan N, Haque M, Guggilam A, Majid DS, Francis J. Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am. J. Physiol. Renal Physiol. 2009;296:F298-F305. DOI |
36 | Liu Y, Zhang R, Qu H, Wu J, Li L, Tang Y. Endothelial microparticles activate endothelial cells to facilitate the inflammatory response. Mol. Med. Rep. 2017;15:1291-1296. DOI |
37 | Hsueh WA, Quinones MA. Creager MJ, Endothelium in insulin resistance and diabetes. Diabetes Rev. 1997;5:343-52. |
38 | Busse R, Fleming I. The endothelial organ. Curr Op Cardiol. 1993;8:719-27. DOI |
39 | Mitchell CJ, Churchward-Venne TA, West DW, Burd NA, Breen L, Baker SK, Phillips SM. Resistance exercise load does not determine training-mediated hypertrophic gains in young men. J Appl Physiol, 2012;113:71-77. DOI |
40 | Chou TC, Yen MH, Li CY, Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 1998;31:643-648. DOI |
41 | Gibbons GH, Dzau VJ. Molecular therapy for vascular diseases. Science. 1996;272:689-93. DOI |
42 | Reiling N, Kroncke R, Ulmer AJ. Nitric oxide of synthase:expression the endothelial, Ca2+/calmodulin-dependent isoform in human B and T lymphocytes. Eur J Immunol. 1996;26:511-6. DOI |
43 | Shaul PW, North AJ, Wu LC. Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J Clin Invest. 1994;94:2231-6. DOI |
44 | Chou TC, Yen MH, Li CY, Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension. 1998;31:643-8. DOI |
45 | Ahmad A, Dempsey SK, Daneva Z, Azam M, Li N, PL Li, Ritter JK. Role of Nitric Oxide in the Cardiovascular and Renal Systems. Int J Mol Sci. 2018 Sep 3;19(9):2605. DOI |
46 | Grossi L. Hydrogen sulfide induces nitric oxide release from nitrite. Bioorg. Med. Chem. Lett. 2009;19:6092-6094. DOI |
47 | Brouwers S, Sudano I, Kokubo Y, Sulaica EM. Arterial hypertension. Lancet. 2021; Jul 17;398(10296): 249-261. DOI |
48 | Liu W, Tang F, Deng Y, Li X, Lan T, Zhang X. Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition. Mol Cell Biochem. 2009;325:99. DOI |
49 | Katholi RE, Couri DM. Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens. 2011;495349. |
50 | Messerli FH, Rimoldi SF, Bangalore S. The transition from hypertension to heart failure: contemporary update. JACC Heart Fail. 2017;5: 543-551. DOI |